Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by AP Aleksankin
SAT0232 B-Cell Subpopulation Dynamics in Sle Patients Following Rituximab Therapy
Related publications
B Cell Therapy for Rheumatoid Arthritis: The Rituximab (Anti-Cd20) Experience
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Tolerability of Obinutuzumab Therapy in Patients With Rituximab-Relapsed/Refractory B-Cell Malignancies - A Retrospective Single Center Cohort Study
Oncotarget
Oncology
The Rituximab Maintenance Therapy Improves Prognosis of Transformed Diffuse Large B Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Effect of Rituximab on B Cell Phenotype and Serum B Cell-Activating Factor Levels in Patients With Thrombotic Thrombocytopenic Purpura
Clinical and Experimental Immunology
Allergy
Immunology
Rituximab Therapy in Greek Patients With Rheumatoid Arthritis
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Outcomes of Patients With Large B‐Cell Lymphomas and Progressive Disease Following CD19‐Specific CAR T‐Cell Therapy
American Journal of Hematology
Hematology
Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B-Cell Lymphoma
American Journal of Hematology
Hematology
Maintenance Rituximab Is Associated With Improved Overall Survival in Mantle Cell Lymphoma Patients Responding to Induction Therapy With Bendamustine + Rituximab (Br)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Anti-B Cell Therapy in Patients With Systemic Lupus Erythematosus
Modern Rheumatology Journal
